Euromedis Group: Half-Year Results 2024

Euromedis Groupe has communicated its half-year results for 2024, adopted by the Board of Directors on October 25. The accounts as of June 30 reveal a significant drop in turnover, from €24.7 million in 2023 to €18.3 million in 2024, a decrease of 26%.

The company nevertheless recorded an improvement in its gross margin, which reached 5.3 million euros, representing 29% of turnover. This increase was however offset by an increase in transport costs, influenced by global geopolitical instability.

Operating results show a significant reduction in losses, with net income falling from -€5.6 million to -€0.5 million. The outlook for the second half remains cautious, due to geopolitical uncertainties.